clinical severity of macrothrombocytopenia and anemia and are associated with variable skewed X inactivation. Human Molecular Genetics, 11, 147–152. Gurbuxani, S., Vyas, P. & Crispino, J.D. (2003) Recent insights into the mechanisms of myeloid leukemogenesis in Down syndrome. Blood, 103, 399–406. Martyre, M.C., Steunou, V., LeBousse-Kerdiles, M.C. & Wietzerbin, J. (2003) Lack of alteration in GATA-1 expression in CD34+ hematopoietic progenitors from patients with idiopathic myelofibrosis. Blood, 101, 5087–5088; author reply, 5088–5089. Nichols, K.E., Crispino, J.D., Poncz, M., White, J.G., Orkin, S.H., Maris, J.M. & Weiss, M.J. (2000) Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1. Nature Genetics, 24, 266–270. Shivdasani, R.A., Fujiwara, Y., McDevitt, M.A. & Orkin, S.H. (1997) A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development. EMBO Journal, 16, 3965–3973. Vannucchi, A.M., Bianchi, L., Cellai, C., Paoletti, F., Rana, R.A., Lorenzini, R., Migliaccio, G. & Migliaccio, A.R. (2002) Development of myelofibrosis in mice genetically impaired for GATA-1 expression (GATA-1(low) mice). Blood, 100, 1123–1132. Vyas, P., Ault, K., Jackson, C.W., Orkin, S.H. & Shivdasani, R.A. (1999) Consequences of GATA-1 deficiency in megakaryocytes and platelets. Blood, 93, 2867–2875. Yu, C., Niakan, K.K., Matsushita, M., Stamatoyannopoulos, G., Orkin, S.H. & Raskind, W.H. (2002) X-linked thrombocytopenia with thalassemia from a mutation in the amino finger of GATA-1 affecting DNA binding rather than FOG-1 interaction. Blood, 100, 2040–2045.
[1]
T. Kyo,et al.
Chronic myelogenous leukemia with e13a3 (b2a3) type of BCR‐ABL transcript having a DNA breakpoint between ABL exons a2 and a3
,
2003,
American journal of hematology.
[2]
S. Kofman,et al.
BCR/ABL p210, p190 and p230 fusion genes in 250 Mexican patients with chronic myeloid leukaemia (CML).
,
2002,
Clinical and laboratory haematology.
[3]
J. Melo.
BCR-ABL gene variants.
,
1997,
Bailliere's clinical haematology.
[4]
K. Tanaka,et al.
Influence of M-BCR breakpoint sites on the duration of chronic phase in 100 patients with chronic myelocytic leukemia.
,
1993,
Cancer genetics and cytogenetics.
[5]
G. Saglio,et al.
New type of Bcr/Abl junction in Philadelphia chromosome-positive chronic myelogenous leukemia.
,
1990,
Blood.